Topical aminoglycoside ototoxicity: attempting to protect the cochlea

B J Conlon1, D W Smith

  • 1Hearing Research Laboratories, Division of Otolaryngology-Head and Neck Surgery, Duke University Medical Center, Durham, North Carolina, USA. bconlon@iol.ie

Acta Oto-Laryngologica
|October 20, 2000
PubMed

Insights

Alpha lipoic acid offers partial protection against neomycin-induced cochlear damage from topical application. While neomycin alone caused rapid hearing loss, alpha lipoic acid slowed the rate of cochlear damage in this animal study.

Area of Science:

  • Ototoxicity research
  • Pharmacology
  • Neuroscience

Background:

  • Topical aminoglycoside antibiotics applied to the round window membrane can cause cochlear damage.
  • Alpha lipoic acid, a free radical scavenger, has previously shown protection against systemically administered aminoglycosides.

Purpose of the Study:

  • To investigate the protective effects of alpha lipoic acid against cochlear damage induced by topical neomycin application.
  • To determine if alpha lipoic acid's protective mechanism extends to direct application on the round window membrane.

Main Methods:

  • Animals received neomycin (5%) or neomycin plus alpha lipoic acid (50 mg/ml) via osmotic pumps directly to the round window membrane for 7 days.
  • Auditory sensitivity was monitored using auditory nerve compound action potentials (CAPs).
  • Control animals received normal saline.

Main Results:

  • Neomycin alone caused rapid and profound hearing loss, maximal by day 6.
  • Neomycin with alpha lipoic acid also resulted in significant cochlear damage, but the deterioration rate was slower compared to neomycin alone.
  • Control animals maintained normal hearing thresholds throughout the study.

Conclusions:

  • Alpha lipoic acid provides a degree of protection against topical neomycin-induced cochlear damage.
  • The findings suggest that free radical scavenging may play a role in mitigating ototoxicity from direct aminoglycoside application.
  • Further research is warranted to explore therapeutic strategies for preventing aminoglycoside-induced hearing loss.

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
The Cochlea01:13

The Cochlea

The cochlea is a coiled structure in the inner ear that contains hair cells—the sensory receptors of the auditory system. Sound waves are transmitted to the cochlea by small bones attached to the eardrum called the ossicles, which vibrate the oval window that leads to the inner ear. This causes fluid in the chambers of the cochlea to move, vibrating the basilar membrane.
Anatomy of the Ear01:16

Anatomy of the Ear

Auditory sensation, commonly called hearing, involves the transformation of sonic waves into neural impulses facilitated by the structures of the auditory organ. The prominent, flesh-like structure on the side of the head, called the auricle, directs sound waves towards the auditory canal. The auricle is often mislabeled as the pinna, a term more aligned with mobile structures like a feline's external ear. The auditory canal penetrates the cranium via the external auditory meatus of the...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...